Dow Up0.71% Nasdaq Up0.75%




News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


  • Income Statement
  • Balance Sheet
  • Cash Flow

Actelion Ltd. (ALIOF)

-Other OTC
116.62 Down 1.58(1.34%) 11:25AM EDT
ProfileGet Profile for:
Actelion Ltd.
Gewerberstrasse 16
Allschwil, 4123
Switzerland - Map
Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Index Membership:N/A
Full Time Employees:2,396

Business Summary 

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for diseases with unmet medical needs. Its products include Tracleer, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH), a chronic and life-threatening disorder that severely compromises the functions of the lungs and heart; Opsumit, an orally available endothelin receptor antagonist; and Valchlor, a chemotherapeutic agent for the treatment of mycosis fungoides, a common type of cutaneous T-cell lymphoma. The company also provides Veletri, a formulation of epoprostenol for the treatment of PAH; Ventavis, an inhaled formulation of iloprost for the treatment of PAH; and Zavesca, an oral treatment for patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is unsuitable. Actelion Ltd markets its products in Switzerland, the United States, Japan, China, Russia, and Mexico. The company was founded in 1997 and is headquartered in Allschwil, Switzerland.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Actelion Ltd.

Key Executives 
Mr. Jean-Paul Clozel M.D., 59
Founder, Chief Exec. Officer, Member of Management Board and Director
Mr. Andr C. Muller , 51
Chief Financial Officer, Member of The Management Board and Exec. Vice-Pres
Ms. Martine Clozel , 59
Chief Scientific Officer, Sr. VP and Member of the Management Board
Mr. Marian Borovsky , 45
Sr. VP, Group Gen. Counsel, Corp. Sec. and Member of the Management Board
Mr. Otto Schwarz , 59
Chief Operating Officer, Exec. VP and Member of the Management Board
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.